Clozapine use and outcomes among patients with treatment resistant schizophrenia

Australasian Psychiatry

Volumn 19, Issue 5, 2011, Pages 410-414

  El Badri, Selim ^a   Mellsop, Graham ^b  

^a WAIKATO HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

clozapine therapy; culture; ethnicity; schizophrenia; treatment resistance

Indexed keywords

CLOZAPINE;

ADULT; AGGRESSION; ARTICLE; DATA BASE; ETHNICITY; FEMALE; GENDER; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RATING SCALE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; ETHNIC GROUPS; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEX FACTORS;

EID: 80054082826     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.3109/10398562.2011.602078     Document Type: Article

References (21)

1. Jablensky A. Epidemiology of schizophrenia: The global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience 2000; 250 : 274-285. (Pubitemid 32002381)
2. Kulhara P, Chakrabarti S. Culture and schizophrenia and other psychotic disorders. Psychiatric Clinics of North America 2001; 24 : 449-464. (Pubitemid 32912063)
3. Conley RR, Kelly DL. Management of treatment-resistant schizophrenia. Biological Psychiatry 2001; 50 : 898-911.
4. American Psychiatric Association. APA Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006 Washington DC: APA.
5. Lindenmayer JP. Treatment refractory schizophrenia. Psychiatric Quarterly 2000; 7 1 : 373-384.
6. Kerwin R. When should clozapine be initiated in schizophrenia? Some arguments for and against earlier use of Clozapine. CNS Drugs 2007; 21 : 267-278. (Pubitemid 46598448)
7. Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of secondgeneration antipsychotics in patients with treatment-resistant schizophrenia: Areview and meta-analysis of randomized trials. American Journal of Psychiatry 2001; 158 : 518-526. (Pubitemid 32289814)
8. Gaines P, Bower A, Buckingham W, Eagar K, Burgess P, Green J. New Zealand Mental Health Classification and Outcomes Study: Final Report Auckland: Health Research Council of New Zealand, 2003.
9. Eagar K, Gaines P, Burgess P et al. Developing a New Zealand casemix classification for mental health services. World Psychiatry 2004; 3 :172-177.
10. MaGPIe Research Group. Mental disorders among Maori attending their general practitioner. Australian and New Zealand Journal of Psychiatry 2005; 39 : 401-406.
11. Baxter J, Kokaua J, Wells JE, McGee MA, Oakley Browne MA, for the New Zealand Mental Health Survey Research Team. Ethnic comparisons of the 12 month prevalence of mental disorders and treatment contact in Te Rau Hinengaro: The New Zealand Mental Health Survey. Australian and New Zealand Journal of Psychiatry 2006; 40 : 905-913. (Pubitemid 44309107)
12. Tapsell R, Mellsop G. The contributions of culture and ethnicity to New Zealand mental health research findings. International Journal of Social Psychiatry 2007; 53 : 317-24. (Pubitemid 47034366)
13. Mellsop G, Dutu G, El-Badri S. CAOScontribution to understanding cultural/ethnic differences in the prevalence of bipolar affective disorder in New Zealand. Australian and New Zealand Journal of Psychiatry 2007; 41 : 392-396. (Pubitemid 46705712)
14. Wing J K, Beevor AS, Curtis RH, Park S, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS). British Journal of Psychiatry 1998; 172 : 11-18.
15. Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. Psychiatric Quarterly 2006; 77 : 81-95. (Pubitemid 43060798)
16. Wheeler, A. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Annals of Pharmacotherapy 2008; 42 : 852-860. (Pubitemid 351778093)
17. Susser E, Wanderling J. Epidemiology of nonaffective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting. Archives of General Psychiatry 1994; 51: 294-301. (Pubitemid 24127302)
18. Navarro F, van Os J, Jones P, Murray R. Explaining sex differences in course and outcome in the functional psychoses. Schizophrenia Research 1996; 21 : 161-170. (Pubitemid 26298408)
19. Szymanski S, Lieberman J, Pollack S et al. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Biological Psychiatry 1996; 39 : 249-254. (Pubitemid 26083148)
20. Werry JS. Child and adolescent (early onset) schizophrenia: Areview in light of DSMIII-R. Journal of Autism and Developmental Disorders 1992; 22 : 601-624.
21. Tiihonen J, Lönnqvist J, Wahlbeck K et al. 11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study). Lancet 2009; 374 : 620-627.